Search research articles
Contact Us
Filters
Showing results (141-150 of 164) with videos related to
Page
of 17
Sort By:
Clinical Genitourinary Cancer
|
March 5, 2017
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?
Charles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 12, 2021
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial
Rachel Galot, Christophe Le Tourneau, Esma Saada-Bouzid, et al.
The Lancet. Oncology
|
February 13, 2019
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial
Johann S de Bono, Nicole Concin, David S Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2019
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
David S Hong, Nicole Concin, Ignace Vergote, et al.
ESMO Open
|
August 28, 2020
Oncological care organisation during COVID-19 outbreak
Concetta Elisa Onesti, Hope S Rugo, Daniele Generali, et al.
Cancer Research
|
August 30, 2014
Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling
Shan Gao, Ilirjana Bajrami, Clare Verrill, et al.
Cancer Cell
|
December 12, 2018
The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients
Marc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2026
Molecular and immune landscape of recurrent and/or distant metastatic squamous cell carcinoma of the head and neck: an EORTC/IMMUCAN project
Athénaïs van der Elst, Daniel Herrero-Saboya, Lucas Michon, et al.
JCO Precision Oncology
|
February 1, 2022
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations
David M Hyman, Ben Tran, Luis Paz-Ares, et al.
Cancer Research Communications
|
February 21, 2025
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors
Valentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 164) with videos related to
Sort By:
Page
of 17
Clinical Genitourinary Cancer
|
March 5, 2017
Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?
Charles Van Praet, Sylvie Rottey, Fransien Van Hende, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 12, 2021
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial
Rachel Galot, Christophe Le Tourneau, Esma Saada-Bouzid, et al.
The Lancet. Oncology
|
February 13, 2019
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial
Johann S de Bono, Nicole Concin, David S Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2019
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
David S Hong, Nicole Concin, Ignace Vergote, et al.
ESMO Open
|
August 28, 2020
Oncological care organisation during COVID-19 outbreak
Concetta Elisa Onesti, Hope S Rugo, Daniele Generali, et al.
Cancer Research
|
August 30, 2014
Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling
Shan Gao, Ilirjana Bajrami, Clare Verrill, et al.
Cancer Cell
|
December 12, 2018
The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients
Marc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2026
Molecular and immune landscape of recurrent and/or distant metastatic squamous cell carcinoma of the head and neck: an EORTC/IMMUCAN project
Athénaïs van der Elst, Daniel Herrero-Saboya, Lucas Michon, et al.
JCO Precision Oncology
|
February 1, 2022
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations
David M Hyman, Ben Tran, Luis Paz-Ares, et al.
Cancer Research Communications
|
February 21, 2025
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors
Valentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz, et al.
Page
of 17